Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluoxetine for Refractory Constipation
NCT06750445Completed
- Start
- Jan 2020
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of fluoxetine in constipation (2 arms). Primary endpoint: Proportion of patients with a CSBM of 3 or more per week at 6 months. Started Jan 2020; status: completed.
02
Drugs
fluoxetine
03
Conditions
constipation
Beyond the preview
Go deeper on NCT06750445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06750445.